| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/01/2003 | US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole |
| 05/01/2003 | US20030083348 Farnesyl transferase inhibitors |
| 05/01/2003 | US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/01/2003 | US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP) |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 05/01/2003 | US20030083319 For treating osteoporosis, secondary hyperparathyroidism, cancer and autoimmune diseases without inducing hypercalciuria, hypercalcemia, or nephrotoxicity |
| 05/01/2003 | US20030083316 Dioxolane nucleosides and nucleoside analogues such as troxacitabine together with chemotherapeutic agents other than doxorubicin such as cytarabine, gemcitabine and idarubicin; synergistic mixture; treating leukemia, cancer |
| 05/01/2003 | US20030083313 Means of tumor therapy |
| 05/01/2003 | US20030083296 Antisense modulation of caspase 8 expression |
| 05/01/2003 | US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving |
| 05/01/2003 | US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides |
| 05/01/2003 | US20030083272 Sense mrna therapy |
| 05/01/2003 | US20030083271 Such as 12-(6-deoxy-6-fluoro-D-galactopyranosyl)-3,9-difluoro-12,13-dihydro-5H -indolo(2,3-a)pyrrolo(3,4-c)carbazole -5,7(6H)-dione for inhibiting proliferation of tumor cells |
| 05/01/2003 | US20030083265 TGF-beta inhibitors and methods |
| 05/01/2003 | US20030083264 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine |
| 05/01/2003 | US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 05/01/2003 | US20030083254 Heparanase-like proteins and nucleotides that encode them |
| 05/01/2003 | US20030083252 Neuronal uses of BMP-11 |
| 05/01/2003 | US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule |
| 05/01/2003 | US20030083242 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/01/2003 | US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation |
| 05/01/2003 | US20030083235 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents |
| 05/01/2003 | US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy |
| 05/01/2003 | US20030082786 PEG-modified uricase |
| 05/01/2003 | US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket |
| 05/01/2003 | US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents |
| 05/01/2003 | US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein |
| 05/01/2003 | US20030082722 Method for amplifying expression from a cell specific promoter |
| 05/01/2003 | US20030082685 Chemotherapeutic induction of egr-1 promoter activity |
| 05/01/2003 | US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 05/01/2003 | US20030082622 Crystalline polypeptide for use in the treatment of tumor and cardiovascular and respiratory system disorders |
| 05/01/2003 | US20030082620 Novel human genes and gene expression products: II |
| 05/01/2003 | US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor |
| 05/01/2003 | US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics |
| 05/01/2003 | US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders |
| 05/01/2003 | US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 05/01/2003 | US20030082224 Antitumor, anticancer agents |
| 05/01/2003 | US20030082207 Method of using HIV protease inhibiting compounds |
| 05/01/2003 | US20030082201 Genetic engineering; polymerase chain reaction |
| 05/01/2003 | US20030082195 Method of enhancing an immune response |
| 05/01/2003 | US20030082184 Uses of mammalian cytokine; related reagents |
| 05/01/2003 | US20030082175 April receptor (BCMA) and uses thereof |
| 05/01/2003 | US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 05/01/2003 | US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 05/01/2003 | US20030082160 Differentiation of whole bone marrow |
| 05/01/2003 | US20030082150 Recombinant adenoviral vectors for human tumour gene therapy |
| 05/01/2003 | US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy |
| 05/01/2003 | US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer |
| 05/01/2003 | US20030082107 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 05/01/2003 | US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions |
| 05/01/2003 | US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 05/01/2003 | CA2498591A1 Immunotherapy for reversing immune suppression |
| 05/01/2003 | CA2471532A1 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 05/01/2003 | CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 05/01/2003 | CA2464790A1 Treatment of acute myeloid leukemia with indolinone compounds |
| 05/01/2003 | CA2464700A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 05/01/2003 | CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 05/01/2003 | CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 05/01/2003 | CA2464394A1 Methods and compositions for inducing tumor-specific cytotoxicity |
| 05/01/2003 | CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/01/2003 | CA2464344A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | CA2464311A1 Derivatives of etoposide and analogs, and pharmaceutical compositions containing them |
| 05/01/2003 | CA2464271A1 Integrin targeting compounds |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 05/01/2003 | CA2464239A1 Psma antibodies and protein multimers |
| 05/01/2003 | CA2463923A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 05/01/2003 | CA2463902A1 Functionalized stilbene derivatives as improved vascular targeting agents |
| 05/01/2003 | CA2463101A1 Azole derivatives and pharmaceutical compositions containing them |
| 05/01/2003 | CA2461661A1 Use of histamine to treat liver disease |
| 05/01/2003 | CA2461085A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 05/01/2003 | CA2460680A1 Substituted indazole compounds for the treatment of inflammation |
| 05/01/2003 | CA2458958A1 Method and apparatus for dispensing inhalator medicament |
| 04/30/2003 | CN1414970A Transgenically produced fusion proteins |
| 04/30/2003 | CN1414956A Substituted piperazine derivatives as MIP inhibitors |
| 04/30/2003 | CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof |
| 04/30/2003 | CN1414952A Heterocyclic compounds having sulfonic acid |
| 04/30/2003 | CN1414865A 癌症的治疗 Treatment of cancer |
| 04/30/2003 | CN1414864A Adhesive particle DNA constructs and method of making and using the same |
| 04/30/2003 | CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 04/30/2003 | CN1414854A Phosphonate compounds |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1414010A Cardiac glycoside type compound for treating carcinosis and its preparation method |
| 04/30/2003 | CN1413731A Macrophage tumor vaccin and its preparation method |
| 04/30/2003 | CN1413695A Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy |
| 04/30/2003 | CN1413674A Health-care liquid, powder for antitumor and prevention and curing |
| 04/30/2003 | CN1413661A Chinese medicine capsule and external used medicine for treating skin carcinoma and its preparation method |
| 04/30/2003 | CN1413659A Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
| 04/30/2003 | CN1413657A Chinese medicine capsule, pill for treating liver cancer and preparation method |
| 04/30/2003 | CN1413652A Specific remedy for hysteromyoma and preparing method |
| 04/30/2003 | CN1413646A Antitumor oral liquid and its preparation method |
| 04/30/2003 | CN1413608A Discorea nipponica and new use of its active component |
| 04/30/2003 | CN1413590A Cancer prevention oral medicine |
| 04/30/2003 | CN1413584A Antitumor oral medicine prepared by Chinese yew extract |
| 04/30/2003 | CN1413581A Pharmaceutical preparation containing northeast cryrtominetin medicinal preparation and its new use |
| 04/30/2003 | CN1413580A Elemene antitumor medicine and its preparation method |
| 04/30/2003 | CN1107068C 2-amino-7-(1-substituted-2-hyroxyethyl)-3.5-diphydro-pyrrolo (3,2-D) pyrimidine-4-ones |
| 04/30/2003 | CN1107058C Subsitituted isoxazoles for treatment of inflammation |
| 04/30/2003 | CN1106858C Vaccine composition having antitumour activity and use there of in therapy of malignant diseases |
| 04/30/2003 | CN1106855C Oral liquid for treating digestive system tumor |
| 04/30/2003 | CN1106836C Sustained release and implantation type fluorouracil medicine and method for preparing same |